Zdrowie i gospodarka · 16.02.2016
Anthrax: Developing Drugs for Prophylaxis of Inhalational Anthrax; Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Anthrax: Developing Drugs for Prophylaxis of Inhalational Anthrax." The purpose of this draft guidance is to assist sponsors in the development of new drugs for the prophylaxis of inhalational anthrax. This draft guidance supersedes the draft guidance entitled "Inhalational Anthrax (Post- Exposure)--Developing Antimicrobial Drugs" issued in March 2002.